References
- Alhnan MA, Murdan S, Basit AW. Encapsulation of poorly soluble basic drugs into enteric microparticles: A novel approach to enhance their oral bioavailability. Int J Pharm, 2011;416:55–60
- Boots AW, Haenen GR, Bast A. Health effect of quercetin: From antioxidant to nutraceutical. Eur J Pharmacol, 2008;585:325–37
- Caddeo C, Teskač K, Sinico C, Kristl J. Effect of resveratrol incorporated in liposomes on proliferation and UV-B protection of cells. Int J Pharm, 2008;363:183–91
- Caddeo C, Manconi M, Fadda AM, Lai F, Lampis S, Diez-Sales O, Sinico C. Nanocarriers for antioxidant resveratrol: Formulation approach, vesicle self-assembly and stability evaluation. Colloid Surf B-Biointerfaces, 2013;111:327–32
- Caddeo C, Díez-Sales O, Pons R, Fernàndez-Busquets X, Fadda AM, Manconi M. Topical anti-inflammatory potential of quercetin in lipid-based nanosystems: In vivo and in vitro evaluation. Pharm Res, 2014;31:959–68
- Chessa M, Caddeo C, Valenti D, Manconi M, Sinico C, Fadda AM. Effect of penetration enhancer containing vesicles on the percutaneous delivery of quercetin through new born pig skin. Pharmaceutics, 2011;3:497–509
- Eftaiha AF, Qinna N, Rashid IS, Al Remawi MM, Al Shami MR, Arafat TA, Badwan AA. Bioadhesive controlled metronidazole release matrix based on chitosan and xanthan gum. Mar Drugs, 2010;8:1716–30
- Korsmeyer RW, Gunny R, Peppas NA. Mechanism of solute release from hydrophilic polymers. Int J Pharm, 1983;15:25–35
- Kristl J, Teskač K, Caddeo C, Abramovič Z, Šentjurc M. Improvements of cellular stress response on resveratrol in liposomes. Eur J Pharm Biopharm, 2009;73:253–9
- Kumar MNVR, Muzzarelli RAA, Muzzarelli C, Sashiwa H, Domb AJ. Chitosan chemistry and pharmaceutical perspectives. Chem Rev, 2004;104:6017–84
- Manach C, Scalbert A, Morand C, Rémésy C, Jiménez L. Polyphenols: Food sources and bioavailability. Am J Clin Nutr, 2004;79:727–47
- Manconi M, Mura S, Manca ML, Fadda AM, Dolz M, Hernandez MJ, Casanovas A, Díez-Sales O. Chitosomes as drug delivery systems for C-phycocyanin: Preparation and characterization. Int J Pharm, 2010;392:92–100
- Mc Callion ONM, Taylor KMG, Thomas M, Taylor AJ. The influence of surface tension on aerosols produced by medical nebulisers. Int J Pharm, 1996;129:123–36
- Mura C, Nácher A, Merino V, Merino-Sanjuán M, Manconi M, Loy G, Fadda AM, Díez-Sales O. Design, characterization and in vitro evaluation of 5-aminosalicylic acid loaded n-succinyl-chitosan microparticles for colon specific delivery. Colloid Surf B-Biointerfaces, 2012;94:199–205
- Noory C, Tran N, Ouderkirk L, Shah V. Steps for development of a dissolution test for sparingly water-soluble drug products. Am Pharmaceut Rev, 2002;5:16–20
- Pinto JF. Site-specific drug delivery systems within the gastro-intestinal tract: From the mouth to the colon. Int J Pharm, 2010;395:44–52
- Rahman SMH, Telny TC, Ravi TK, Kuppusamy S. Role of surfactant and pH in dissolution of curcumin. Indian J Pharm Sci, 2009;71:139–42
- Shan BE, Wang MX, Li RQ. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/β-catenin signaling pathway. Cancer Invest, 2009;27:604–12
- Siepmann J, Peppas NA. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev, 2001;48:139–57
- Singhal A, Hain J, Singhal V, Elias EJ, Showkat A. Colon-targeted quercetin delivery using natural polymer to enhance its bioavailability. Pharmacognosy Res, 2011;3:35–9
- Sinico C, Caddeo C, Valenti D, Fadda AM, Bilia AR, Vincieri FF. Liposomes as carriers for verbascoside: Stability and skin permeation studies. J Liposome Res, 2008;18:83–90
- Xu Q, Tanaka Y, Czernuszka JT. Encapsulation and release of a hydrophobic drug from hydroxyapatite coated liposomes. Biomaterials, 2007a;28:2687–94
- Xu Y, Zhan C, Fan L, Wang L, Zheng H. Preparation of dual crosslinked alginate-chitosan blend gel beads and in vitro controlled release in oral site specific drug delivery system. Int J Pharm, 2007b;336:329–37